Percentage of Cholangitis Before ERCP
The provided evidence does not contain specific percentage data on how many patients present with acute cholangitis before undergoing ERCP. However, based on the available research, I can provide the following clinical context:
Available Data on Pre-ERCP Cholangitis
In one recent study examining post-ERCP acute kidney injury, acute cholangitis was present as the indication for ERCP in 30% of cases 1. This suggests that roughly one-third of patients undergoing ERCP may have cholangitis at presentation, though this represents a single-center experience.
Another multicenter study examining malignant distal biliary obstruction found that approximately 12% (80 out of 588 patients) had pre-ERCP cholangitis 2. However, this specifically addresses malignant obstruction rather than the broader ERCP population.
Clinical Context
The guidelines emphasize that:
- Acute cholangitis is a potentially life-threatening condition requiring urgent biliary decompression 3
- Initial medical management to stabilize hemodynamics and treat infection should precede the procedure 3
- In the setting of acute cholangitis, biliary decompression can be lifesaving 3
Key Clinical Implications
When cholangitis is present before ERCP:
- Higher risk of bacteremia: One study found an 11.3% rate of positive blood cultures in patients undergoing ERCP with biliary obstruction 4
- Biliary bacterial colonization was present in 56% of patients with biliary obstruction, with E. coli, Enterococcus, and Klebsiella being most common 4
- Pre-ERCP cholangitis is an independent predictor of post-ERCP acute kidney injury 1
Common Pitfall
The absence of specific population-based percentages in major guidelines suggests this varies significantly by referral pattern, disease etiology (benign vs. malignant), and clinical setting. Teaching hospitals and tertiary centers likely see higher rates of pre-existing cholangitis compared to community settings.
The best available estimate suggests 10-30% of patients have acute cholangitis before ERCP, with variation based on indication and patient population.